About Us

Inception and Growth

Elegant Pharmaceuticals Ltd is marking its footprints on canvas of global pharmaceutical / Life science sector, rapidly. Elegant commenced operations in 1994 as a bulk drug manufacturer and, is today diversified and grown as manufacturing & marketing Life Science organisation. Elegant is one of the experienced players in the pharmaceutical formulation and therapeutic segments. We cater to most categories with unique health solutions and many new product categories are being evolved.


Our Strengths

Product Portfolio with many special and unique products.

Manufacturing facilities with GMP, WHO GMP, EU GMP, CGMP OF PIC/S, INVIMA - Colombia, TGA Australia & ISO certification

Continuous Research and Development for Products and Markets.

Customer Support, Service and dedicated

Our product portfolio includes major life science products of various products groups in forms of Tablets, Capsules, Injectables, Liquid orals and Dry powder injections etc. All products are manufactured at our world class facilities meeting International Standards and government norms.


Our Basic API

Our business strategy is simple: We Strongly believe in innovation & introduction of new concepts. Our strategy of building a niche and bringing difference through our product and services has generated enhanced market penetration & driven higher market recall than operating in 'me-too' markets. Since inception, we have followed this strategy which helped us carve a niche for value we provide to our customers through products and services. We welcome challenges and adoptable to market dynamics which has rewarded us with long term sustainability.

Way We Operate

We conduct our business in line with global business practices and systems. We strongly believe that customer has every right to demand best quality at a competitive price and with quicker delivery schedule. Our Customers remain our partners of our growth and value generation.

We believe that, enormous opportunities still exist at global business environment. We welcome you to join us as our partners for mutual progress and satisfying business opportunities.


Our Growth Engine

Elegant has created an extensive intellectual asset base through a powerful research & development division. Intellectual capital represents our principal asset, which sustains our brand leadership in the markets of our presence.

Our strategic alliances with a number of global pharmaceutical entities and trade organisations for offering our products at international markets and our acquisitions have strengthened and enabled us to become a true-global pharmaceutical company.